Drug Shortage Report for ADLYXINE
Report ID | 154488 |
Drug Identification Number | 02464276 |
Brand name | ADLYXINE |
Common or Proper name | Adlyxine |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | LIXISENATIDE |
Strength(s) | 10MCG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 1 |
ATC code | A10BJ |
ATC description | |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2022-02-01 |
Estimated end date | 2022-03-31 |
Actual end date | 2022-03-24 |
Shortage status | Resolved |
Updated date | 2022-03-29 |
Company comments | Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-03-29 | French | Compare |
v5 | 2022-03-29 | English | Compare |
v4 | 2022-03-16 | French | Compare |
v3 | 2022-03-16 | English | Compare |
v2 | 2022-02-08 | French | Compare |
v1 | 2022-02-08 | English | Compare |
Showing 1 to 6 of 6